282 related articles for article (PubMed ID: 19271376)
21. Pruritic eruption on the chest.
Chwen CC
J Fam Pract; 2014 Nov; 63(11):677-9. PubMed ID: 25362492
[TBL] [Abstract][Full Text] [Related]
22. Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
Bragg J; Pomeranz MK
Dermatol Online J; 2007 Jan; 13(1):1. PubMed ID: 17511934
[TBL] [Abstract][Full Text] [Related]
23. Papulo-pustular eruption during cetuximab treatment.
Satta R; Cuccuru MA; Pirodda C; Cottoni F
G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
[No Abstract] [Full Text] [Related]
24. Cetuximab-induced acne.
Molinari E; De Quatrebarbes J; André T; Aractingi S
Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741
[TBL] [Abstract][Full Text] [Related]
25. [Cutaneous side effects of EGFR inhibitors--appearance and management].
Wollenberg A; Kroth J; Hauschild A; Dirschka T
Dtsch Med Wochenschr; 2010 Jan; 135(4):149-54. PubMed ID: 20101558
[TBL] [Abstract][Full Text] [Related]
26. [Acneiform skin eruption in patients with metastatic colorectal carcinoma].
Gethöffer K; Schneider LA; Peters T; Weber L; Scharffetter-Kochanek K
Hautarzt; 2006 Jul; 57(7):628-31. PubMed ID: 16034631
[No Abstract] [Full Text] [Related]
27. When Acne is Not Acne.
Del Rosso JQ; Silverberg N; Zeichner JA
Dermatol Clin; 2016 Apr; 34(2):225-8. PubMed ID: 27015783
[TBL] [Abstract][Full Text] [Related]
28. Fungal folliculitis masquerading as acute exanthematous pustulosis.
Sharma T; Vij A; Sood A
Cleve Clin J Med; 2016 Mar; 83(3):179-80. PubMed ID: 26974987
[No Abstract] [Full Text] [Related]
29. An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; D'Aguanno K; Oliel S; Zeng Y; Esfahani K; Pehr K
J Cutan Med Surg; 2023 Nov; 27(6):614-620. PubMed ID: 37942582
[TBL] [Abstract][Full Text] [Related]
30. Papular follicular eruptions in human immunodeficiency virus-positive patients in South Africa.
Budavari JM; Grayson W
Int J Dermatol; 2007 Jul; 46(7):706-10. PubMed ID: 17614798
[TBL] [Abstract][Full Text] [Related]
31. Cetuximab-associated folliculitis predominantly affecting the lower limbs.
Oberholzer PA; Borradori L; Beltraminelli H
J Dtsch Dermatol Ges; 2011 Sep; 9(9):703-4. PubMed ID: 21627774
[No Abstract] [Full Text] [Related]
32. [Acneiform eruption secondary to cetuximab].
Herrera-Acosta E; Martín-Ezquerra G; Iglesias M; Umbert P
Actas Dermosifiliogr; 2005 May; 96(4):252-4. PubMed ID: 16476378
[TBL] [Abstract][Full Text] [Related]
33. A case of successfully treated recalcitrant EGFR inhibitor-induced acneiform eruption following non-ablative fractional laser.
Choi JW; Kim TI; Jeong KH; Shin MK
Dermatol Ther; 2016 Jul; 29(4):252-4. PubMed ID: 27146102
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy.
Micantonio T; Fargnoli MC; Ricevuto E; Ficorella C; Marchetti P; Peris K
Arch Dermatol; 2005 Sep; 141(9):1173-4. PubMed ID: 16172328
[No Abstract] [Full Text] [Related]
35. Cetuximab-induced cutaneous toxicity.
Tomková H; Kohoutek M; Zábojníková M; Pospísková M; Ostrízková L; Gharibyar M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):692-6. PubMed ID: 19925598
[TBL] [Abstract][Full Text] [Related]
36. Complications of therapy and a diagnostic dilemma case. Case 2. Cutaneous toxicity induced by cetuximab.
Monti M; Mancini LL; Ferrari B; Rahal D; Santoro A
J Clin Oncol; 2003 Dec; 21(24):4651-3. PubMed ID: 14673056
[No Abstract] [Full Text] [Related]
37. Phytomenadione pre-treatment in EGFR inhibitor-induced folliculitis.
Tomková H; Pospíšková M; Zábojníková M; Kohoutek M; Serclová M; Gharibyar M; Sternberský J
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):514-9. PubMed ID: 22035385
[TBL] [Abstract][Full Text] [Related]
38. An outbreak of Candida albicans folliculitis masquerading as Malassezia folliculitis in a prison population.
Jalalat S; Hunter L; Yamazaki M; Head E; Kelly B
J Correct Health Care; 2014 Apr; 20(2):154-62. PubMed ID: 24659762
[TBL] [Abstract][Full Text] [Related]
39. Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer.
Waris W; Naik S; Idrees I; Taha H; Camosino L; Mehrishi A; Saif MW
Cutan Ocul Toxicol; 2009; 28(1):41-4. PubMed ID: 19514925
[TBL] [Abstract][Full Text] [Related]
40. EGFR inhibitor-associated acneiform folliculitis: assessment and management.
Duvic M
Am J Clin Dermatol; 2008; 9(5):285-94. PubMed ID: 18717603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]